Proequities, Inc.
- SEC CIK
- 0000752798
- Latest filing
- Aug 12, 2025
ZNTL holding history
Zentalis Pharmaceuticals, Inc. in every 13F filed by Proequities, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZNTL overviewAll 13F holders of ZNTLFull Q2 2025 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −100−100.0% | Sold out | Holders |
| Q4 2024 | 100 | $226 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 100 | $368 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 100 | $409 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 100 | $1.58K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 100 | $1.51K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 100 | $2.01K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 100 | $2.82K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 100 | $1.72K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 100 | $2.01K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 100 | $2.00K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 100 | $3.00K | <0.1% | +100 | New | Holders |